Jun 10, 2020
BryoLogyx Announces Agreements with Neurotrope to Acquire Bryostatin-1 Immuno-Oncology Data Package, Supply Synthetic Bryostatin-1
May 13, 2020
COVID-19 Prompts New Home Test for Kids with Organ Transplants
Mar 10, 2020
Sirolimus Market Insights 2020-2025: Anticipating a CAGR of 4.1%, Worldwide
Jan 22, 2020
Neurotrope Provides Corporate Update After Completing Bryostatin-1 Data Analysis for Advanced Alzheimer's Disease Trial
Nov 12, 2019
Veloxis Pharmaceuticals Announces Financial Results for the First Nine Months of 2019
Oct 22, 2019
Organ Transplant Immunosuppressant Drugs Market Worth $5.88 Billion by 2026: Grand View Research, Inc.
Oct 17, 2019
Concept Medical is Granted CE Certification for Their Sirolimus Coated MagicTouch Group of Products
Oct 08, 2019
Neurotrope Announces Review of Strategic Alternatives to Maximize Shareholder Value
Sep 09, 2019
Neurotrope Announces Top-line Results From Confirmatory Phase 2 Study of Bryostatin-1 in Moderate to Severe Alzheimer's Disease
Aug 19, 2019
Vascular Therapies Completes Enrollment in the ACCESS Study, a U.S. Phase III Clinical Trial
Aug 13, 2019
Neurotrope Announces Publication Highlighting the Potential of Bryostatin as a Unique Neurorestorative Therapy
Aug 05, 2019
Neurotrope Announces Corporate Update and Reports Second Quarter 2019 Financial Results
Jul 23, 2019
SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent
Jul 15, 2019
Neurotrope Concludes Data Collection in Confirmatory Phase 2 Clinical Trial of Moderately Severe to Severe Alzheimer's Disease
Jul 11, 2019
MeRes100 BRS - the World's First Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffold - Shows Consistent Long-term Positive Safety With Consistent Low MACE rates and Zero Scaffold Stent Thrombosis for Patients With Coronary Artery Disease
Jul 11, 2019
Neurotrope to Present at the Alzheimer's Association International Conference; Neurotrope President and Chief Scientific Officer, Dr. Daniel L. Alkon, to Receive Cure Coin Award; Design of Confirmatory Phase 2 Trial to be Presented
Jun 21, 2019
Sirolimus Market to Touch US$304.08 Billion by 2027; Improving Healthcare Infrastructure to Bolster the Industry Globally - TMR
Jun 13, 2019
Terumo Enhances Coronary Interventional Product Portfolio By Securing Exclusive Global Rights to Orchestra BioMed's Virtue® Sirolimus-Eluting Balloon (SEB) through Global Strategic Partnership
Jun 03, 2019
Aadi Bioscience Breakthrough Therapy nab-Sirolimus (ABI-009) Preliminary Data Released from the AMPECT Registration Trial in Advanced PEComa
Jun 03, 2019
Neurotrope's President and Chief Scientific Officer to Present at the Alzheimer's Solutions Conference at The University of the Sciences in Philadelphia, PA on June 3rd, 2019